|
Medtronic launches clinical trial of its renal denervation device. |
 |
 |
|
Mass Device: Medtronic (NYSE:MDT) launched U.S. trials of its Simplicity renal denervation system for hypertension with the enrollment of the first patient at the Prairie Heart Institute in Springfield, Ill. Cross-town rival St. Jude Medical (NYSE:STJ) two weeks ago launched a feasibility study of its own renal denervation device two weeks ago. The procedure is used to treat high blood pressure by using a catheter to ablate the nerves lining the renal arteries.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
